Mesenchymal Stem Cells (MSCs) are being investigated as a treatment for a novel viral
disease owing to their immunomodulatory, anti-inflammatory, tissue repair and regeneration …

During the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
many critically ill patients died of severe pneumonia, acute respiratory distress syndrome …

The serious consequences of the global coronavirus disease 2019 (COVID-19) pandemic
have prompted a rapid global response to develop effective therapies that can lessen …

Background Mesenchymal stem/stromal cells (MSCs) and their secreted products are a
promising therapy for COVID-19 given their immunomodulatory and tissue repair …

The outbreak of COVID-19 in December 2019, has become an urgent and serious public
health emergency. At present, there is no effective treatment or vaccine for COVID-19 …

Rationale: Mesenchymal stromal cells (MSCs) may modulate inflammation, promoting repair
in coronavirus disease (COVID-19)–related acute respiratory distress syndrome (ARDS) …

More than seven months into the coronavirus disease-19 (COVID-19) pandemic, infection
from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over …

Corona virus disease 2019 (COVID-19) refers to a type of pneumonia caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Sixty million confirmed …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an enveloped, positive
sense, single stranded RNA (+ ssRNA) virus, belonging to the genus Betacoronavirus and …

Currently, the world is facing the SARS-CoV-2 pandemic, coronavirus of acute respiratory
distress syndrome 2, causes of COVID-19. Coronaviruses are RNA single-stranded viruses …